(Reuters) - The Marlborough, Massachusetts-based drug company said net profit fell to $6.1 million, or 5 cents a share, from $11 million, or 10 cents a share, a year ago.
Revenue rose 5 percent to $278.1 million. Analysts, on average, expected revenue of $327.2 million.
Read more at Reuters.com Hot Stocks News
Revenue rose 5 percent to $278.1 million. Analysts, on average, expected revenue of $327.2 million.
Read more at Reuters.com Hot Stocks News
No comments:
Post a Comment